Understand the source comparison
Peptides and Red Light Therapy Synergy Timing Protocol: Research Application Comparison
Growth Hormone Secretagogues (e.g., MK 677, Ipamorelin) 90–120 minutes (oral), 45–60 minutes (subcutaneous) 810–850nm (near-infrared) Administer peptide, wait 60–90 minutes, apply 5–8 minutes NIR at 25–35 mW/cm² IGF-1-mediated protein synthesis increases 2.8–3
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues (e.g., MK 677, Ipamorelin)
- 90–120 minutes (oral), 45–60 minutes (subcutaneous)
- 810–850nm (near-infrared)
- Administer peptide, wait 60–90 minutes, apply 5–8 minutes NIR at 25–35 mW/cm²
- IGF-1-mediated protein synthesis increases 2.8–3.4× vs peptide alone; lean mass retention improves 40–55% in caloric deficit models
- Collagen Peptides (e.g., BPC-157, TB-500)
- 45–75 minutes (subcutaneous)
- 660nm (red) and 810nm (dual wavelength)
- Administer peptide, wait 45 minutes, apply 4–6 minutes red + NIR at 20–30 mW/cm²
- Collagen type I and III expression increases 3.2× vs peptide alone; wound closure time reduced 35–50% in tissue repair models
- Nootropic Peptides (e.g., Cerebrolysin, Dihexa)
- 30–60 minutes (intranasal or subcutaneous)
- 810nm (near-infrared, transcranial application)
- Administer peptide, wait 30–45 minutes, apply 3–5 minutes NIR to frontal cortex at 15–25 mW/cm²
- BDNF expression in hippocampal tissue increases 2.1× vs peptide alone; synaptic plasticity markers elevated 45–60% in neurogenesis protocols
- Immune Modulators (e.g., Thymalin, KPV)
- 60–90 minutes (subcutaneous)
- 660nm (red, applied to thymic region or inflammation site)
- Administer peptide, wait 60 minutes, apply 4–7 minutes red light at 25–35 mW/cm²
- Thymic output of naïve T-cells increases 38–52%; systemic inflammation markers (CRP, IL-6) decrease 25–40% vs peptide alone